Format
Sort by

Send to

Choose Destination

Search results

Items: 1 to 20 of 918

1.

Thermal and Osmotic Tolerance of 'Irukandji' Polyps: Cubozoa; Carukia barnesi.

Courtney R, Browning S, Northfield T, Seymour J.

PLoS One. 2016 Jul 21;11(7):e0159380. doi: 10.1371/journal.pone.0159380. eCollection 2016.

PMID:
27441693
2.

Extranodal diffuse large B-cell lymphoma (DLBCL) and primary mediastinal B-cell lymphoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up.

Vitolo U, Seymour JF, Martelli M, Illerhaus G, Illidge T, Zucca E, Campo E, Ladetto M; ESMO Guidelines Committee.

Ann Oncol. 2016 Jul 4. pii: mdw175. [Epub ahead of print] Review. No abstract available.

PMID:
27377716
3.

Spatial and temporal variability of aerobic anoxygenic photoheterotrophic bacteria along the east coast of Australia.

Bibiloni-Isaksson J, Seymour J, Ingleton T, van de Kamp J, Bodrossy L, Brown M.

Environ Microbiol. 2016 Jul 4. doi: 10.1111/1462-2920.13436. [Epub ahead of print]

PMID:
27376620
4.

The Dichotic Digits difference Test (DDdT): Development, Normative Data, and Test-Retest Reliability Studies Part 1.

Cameron S, Glyde H, Dillon H, Whitfield J, Seymour J.

J Am Acad Audiol. 2016 Jun;27(6):458-69. doi: 10.3766/jaaa.15084.

PMID:
27310404
5.

Risk Factors and Outcomes for Patients With Follicular Lymphoma Who Had Histologic Transformation After Response to First-Line Immunochemotherapy in the PRIMA Trial.

Sarkozy C, Trneny M, Xerri L, Wickham N, Feugier P, Leppa S, Brice P, Soubeyran P, Gomes Da Silva M, Mounier C, Offner F, Dupuis J, Caballero D, Canioni D, Paula M, Delarue R, Zachee P, Seymour J, Salles G, Tilly H.

J Clin Oncol. 2016 Aug 1;34(22):2575-82. doi: 10.1200/JCO.2015.65.7163. Epub 2016 Jun 13.

PMID:
27298402
6.

Results of a phase II study of thalidomide and azacitidine in patients with clinically advanced myelodysplastic syndromes (MDS), chronic myelomonocytic leukemia (CMML) and low blast count acute myeloid leukemia (AML).

Kenealy M, Patton N, Filshie R, Nicol A, Ho SJ, Hertzberg M, Mills T, Prosser I, Link E, Cowan L, Zannino D, Seymour JF.

Leuk Lymphoma. 2016 Jun 7:1-10. [Epub ahead of print]

PMID:
27268068
7.

New Agents to Treat Chronic Lymphocytic Leukemia.

Roberts AW, Davids MS, Seymour JF.

N Engl J Med. 2016 Jun 2;374(22):2186-7. doi: 10.1056/NEJMc1602674. No abstract available.

PMID:
27248631
8.

A Thematic Synthesis of the Experiences of Adults Living with Hemodialysis.

Reid C, Seymour J, Jones C.

Clin J Am Soc Nephrol. 2016 Jul 7;11(7):1206-18. doi: 10.2215/CJN.10561015. Epub 2016 May 31.

PMID:
27246010
9.

Engaging Terminally Ill Patients in End of Life Talk: How Experienced Palliative Medicine Doctors Navigate the Dilemma of Promoting Discussions about Dying.

Pino M, Parry R, Land V, Faull C, Feathers L, Seymour J.

PLoS One. 2016 May 31;11(5):e0156174. doi: 10.1371/journal.pone.0156174. eCollection 2016.

10.

Plasmablastic Richter transformation as a resistance mechanism for chronic lymphocytic leukaemia treated with BCR signalling inhibitors.

Chan KL, Blombery P, Jones K, Lade S, Carney D, Tran H, Seymour JF, Tam CS.

Br J Haematol. 2016 May 15. doi: 10.1111/bjh.14062. [Epub ahead of print] No abstract available.

PMID:
27196127
11.

Effective mitigation of tumor lysis syndrome with gradual venetoclax dose ramp, prophylaxis, and monitoring in patients with chronic lymphocytic leukemia.

Seymour JF.

Ann Hematol. 2016 Aug;95(8):1361-2. doi: 10.1007/s00277-016-2695-x. Epub 2016 May 14. No abstract available.

PMID:
27179967
12.

Venetoclax in relapsed or refractory chronic lymphocytic leukaemia with 17p deletion: a multicentre, open-label, phase 2 study.

Stilgenbauer S, Eichhorst B, Schetelig J, Coutre S, Seymour JF, Munir T, Puvvada SD, Wendtner CM, Roberts AW, Jurczak W, Mulligan SP, Böttcher S, Mobasher M, Zhu M, Desai M, Chyla B, Verdugo M, Enschede SH, Cerri E, Humerickhouse R, Gordon G, Hallek M, Wierda WG.

Lancet Oncol. 2016 Jun;17(6):768-78. doi: 10.1016/S1470-2045(16)30019-5. Epub 2016 May 10.

PMID:
27178240
13.

Nutrient uplift in a cyclonic eddy increases diversity, primary productivity and iron demand of microbial communities relative to a western boundary current.

Doblin MA, Petrou K, Sinutok S, Seymour JR, Messer LF, Brown MV, Norman L, Everett JD, McInnes AS, Ralph PJ, Thompson PA, Hassler CS.

PeerJ. 2016 Apr 25;4:e1973. doi: 10.7717/peerj.1973. eCollection 2016.

14.

Spatiotemporal Dynamics of Vibrio spp. within the Sydney Harbour Estuary.

Siboni N, Balaraju V, Carney R, Labbate M, Seymour JR.

Front Microbiol. 2016 Apr 12;7:460. doi: 10.3389/fmicb.2016.00460. eCollection 2016.

15.

Development of Telscreen: a telephone-based speech-in-noise hearing screening test with a novel masking noise and scoring procedure.

Dillon H, Beach EF, Seymour J, Carter L, Golding M.

Int J Audiol. 2016 Aug;55(8):463-71. doi: 10.3109/14992027.2016.1172268. Epub 2016 May 3.

PMID:
27138873
16.

Lung cancer diagnosed following an emergency admission: Mixed methods study of the management, outcomes and needs and experiences of patients and carers.

Wilcock A, Crosby V, Hussain A, McKeever TM, Manderson C, Farnan S, Freer S, Freemantle A, Littlewood F, Caswell G, Seymour J.

Respir Med. 2016 May;114:38-45. doi: 10.1016/j.rmed.2016.03.006. Epub 2016 Mar 14.

PMID:
27109809
17.

The BCL2 selective inhibitor venetoclax induces rapid onset apoptosis of CLL cells in patients via a TP53-independent mechanism.

Anderson MA, Deng J, Seymour JF, Tam C, Kim SY, Fein J, Yu L, Brown JR, Westerman D, Si EG, Majewski IJ, Segal D, Heitner Enschede SL, Huang DC, Davids MS, Letai A, Roberts AW.

Blood. 2016 Jun 23;127(25):3215-24. doi: 10.1182/blood-2016-01-688796. Epub 2016 Apr 11.

18.

Advance care planning - a multi-centre cluster randomised clinical trial: the research protocol of the ACTION study.

Rietjens JA, Korfage IJ, Dunleavy L, Preston NJ, Jabbarian LJ, Christensen CA, de Brito M, Bulli F, Caswell G, Červ B, van Delden J, Deliens L, Gorini G, Groenvold M, Houttekier D, Ingravallo F, Kars MC, Lunder U, Miccinesi G, Mimić A, Paci E, Payne S, Polinder S, Pollock K, Seymour J, Simonič A, Johnsen AT, Verkissen MN, de Vries E, Wilcock A, Zwakman M, van der Heide Pl A.

BMC Cancer. 2016 Apr 8;16(1):264. doi: 10.1186/s12885-016-2298-x.

19.

Progress in BCL2 inhibition for patients with chronic lymphocytic leukemia.

Tam CS, Seymour JF, Roberts AW.

Semin Oncol. 2016 Apr;43(2):274-9. doi: 10.1053/j.seminoncol.2016.02.014. Epub 2016 Feb 6. Review.

PMID:
27040706
20.

A qualitative evaluation of the impact of a palliative care course on preregistration nursing students' practice in Cameroon.

Bassah N, Cox K, Seymour J.

BMC Palliat Care. 2016 Mar 31;15:37. doi: 10.1186/s12904-016-0106-7.

Items per page

Supplemental Content

Loading ...
Write to the Help Desk